TW200639176A - Crystal of 1-methyl carbapenem compound - Google Patents

Crystal of 1-methyl carbapenem compound

Info

Publication number
TW200639176A
TW200639176A TW095116812A TW95116812A TW200639176A TW 200639176 A TW200639176 A TW 200639176A TW 095116812 A TW095116812 A TW 095116812A TW 95116812 A TW95116812 A TW 95116812A TW 200639176 A TW200639176 A TW 200639176A
Authority
TW
Taiwan
Prior art keywords
crystal
carbapenem compound
methyl carbapenem
compound
methyl
Prior art date
Application number
TW095116812A
Other languages
English (en)
Inventor
Makoto Michida
Satoshi Kobayashi
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of TW200639176A publication Critical patent/TW200639176A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TW095116812A 2005-05-13 2006-05-12 Crystal of 1-methyl carbapenem compound TW200639176A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2005140683 2005-05-13

Publications (1)

Publication Number Publication Date
TW200639176A true TW200639176A (en) 2006-11-16

Family

ID=37396657

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095116812A TW200639176A (en) 2005-05-13 2006-05-12 Crystal of 1-methyl carbapenem compound

Country Status (5)

Country Link
US (1) US20080227768A1 (zh)
EP (1) EP1880997A4 (zh)
JP (1) JPWO2006121151A1 (zh)
TW (1) TW200639176A (zh)
WO (1) WO2006121151A1 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2536886C (en) * 2003-08-25 2009-10-27 Sankyo Company Limited Crystal of 1-methyl carbapenem compound
WO2006101062A1 (ja) * 2005-03-22 2006-09-28 Daiichi Sankyo Company, Limited １－アルキルピロリジン構造を有するカルバペネム誘導体の製造方法
CH698729B1 (de) * 2007-05-30 2009-10-15 Cerbios Pharma Sa Stabile, kristalline (6S)-N(5)-Methyl-5, 6,7,8-tetrahydrofolsäure.

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997023483A1 (en) * 1995-12-21 1997-07-03 Sankyo Company, Limited 1-methylcarbapenem derivatives
TWI250160B (en) * 1999-07-06 2006-03-01 Sankyo Co Crystalline 1-methylcarbapenem compound
US7041660B2 (en) * 1999-07-06 2006-05-09 Sankyo Company, Limited Crystalline 1-methylcarbapenem derivatives
ES2511774T3 (es) * 2000-05-15 2014-10-23 Takeda Pharmaceutical Company Limited Formas cristalinas de (R)-lansoprazol
JP4327424B2 (ja) * 2000-05-15 2009-09-09 武田薬品工業株式会社 結晶の製造法
JP3681116B2 (ja) * 2000-09-14 2005-08-10 三共株式会社 結晶性カルバペネム化合物を含有する抗菌剤
BR0211489A (pt) * 2001-07-27 2004-08-17 Yamanouchi Pharma Co Ltd Cristal de derivado de ariletenossulfonamida e processo de preparação do mesmo
JP2003277374A (ja) * 2002-03-19 2003-10-02 Nippon Kayaku Co Ltd ピリミドンアセタミド誘導体の新規製造法とその結晶
CA2536886C (en) * 2003-08-25 2009-10-27 Sankyo Company Limited Crystal of 1-methyl carbapenem compound
WO2006101062A1 (ja) * 2005-03-22 2006-09-28 Daiichi Sankyo Company, Limited １－アルキルピロリジン構造を有するカルバペネム誘導体の製造方法
EP2057989A1 (en) * 2006-08-29 2009-05-13 Daiichi Sankyo Company, Limited Freeze-dried preparation of 1-methylcarbapenem

Also Published As

Publication number Publication date
WO2006121151A1 (ja) 2006-11-16
JPWO2006121151A1 (ja) 2008-12-18
EP1880997A1 (en) 2008-01-23
US20080227768A1 (en) 2008-09-18
EP1880997A4 (en) 2009-03-11

Similar Documents

Publication Publication Date Title
RS51954B (en) CRYSTAL MODIFICATIONS OF PYRACLOSTROBIN
WO2007085895A3 (en) Fap inhibitors
TW200716606A (en) Chemical compounds
HK1113352A1 (en) Chemical compounds
HK1114375A1 (en) Chemical compounds
PL1891004T3 (pl) Pentafluorosulfanylo-podstawiony związek i jego zastosowanie do wytwarzania środków leczniczych
TN2012000063A1 (en) Quinazolines as potassium ion channel inhibitors
MX2009003405A (es) Composiciones farmaceuticas de inhibidores de la histona desacetilasa y compuestos quelantes de metal, y complejos de quelato de metal-inhibidor de histona desacetilasa.
RS51445B (en) PYROLIDINDION SUBSTITUTED BY PIPERIDINE-PTHALAZONE AS PDE4 INHIBITORS
MX2008008298A (es) Sal de sulfato de hidrogeno novedosa.
GB0521508D0 (en) Organic compounds
TW200626068A (en) Active compounds for seed treatment
UA94833C2 (en) Substituted bicyclolactams
TW200510301A (en) Novel compounds
TW200510303A (en) Novel compounds
TW200637866A (en) Amino-imidazolones for the inhibition of β-secretase
MX2010002902A (es) Pirimidinas anti-infecciosas y usos de las mismas.
MY159850A (en) Tetracyclic compounds
WO2007008684A3 (en) Ligands of melanocortin receptors
MX2008016039A (es) Preparacion de glucano.
MY144782A (en) Glucuronate salt of a piperazine compound
UA102220C2 (ru) Способ синтеза агомелатина
MX2009005649A (es) Tratamiento para mieloma multiple.
TWI349008B (en) Ionic liquids having fluoroalkyltrifluoroborate anions
MX2009013069A (es) Tratamiento de leucemia resistente al imatinib.